Using MSC exosomes to improve lung health in infants with bronchopulmonary dysplasia.
MSC Exosome Treatment for BPD: Impact on Immunity and Lung Development
This study is looking at how tiny particles from stem cells might help improve lung health in premature babies with bronchopulmonary dysplasia (BPD) by reducing inflammation and supporting lung growth.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston Children's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11047555 on NIH RePORTER |
What this research studies
This research investigates the use of mesenchymal stem cell (MSC) exosomes as a treatment for bronchopulmonary dysplasia (BPD), a serious lung condition affecting premature infants. The study focuses on how these exosomes can reduce inflammation and promote lung development, potentially reversing some of the damage caused by BPD. By utilizing purified MSC-derived small extracellular vesicles, the research aims to provide a novel therapeutic approach to improve long-term health outcomes for affected infants. The methodology includes experimental models that simulate the condition to assess the effectiveness of the treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are premature infants diagnosed with bronchopulmonary dysplasia.
Not a fit: Patients who are not premature or do not have a diagnosis of bronchopulmonary dysplasia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a groundbreaking treatment that significantly improves lung function and overall health in infants suffering from BPD.
How similar studies have performed: Previous research has shown promising results using MSC-derived therapies for similar conditions, indicating potential for success in this approach.
Where this research is happening
Boston, United States
- Boston Children's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Kourembanas, Stella — Boston Children's Hospital
- Study coordinator: Kourembanas, Stella
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.